Get started
Author

Giovanna Farfán-Quiroga

Observed names: G. Farfan‐Quiroga, Giovanna Farfan, Giovanna Farfan-Quiroga
Institution: Hospital San Pedro
Observed institution: Hospital San Pedro
ORCID: 0000-0002-8710-7489
Observed ORCID: 0000-0002-8710-7489
OpenAlex ID: A5036351983
Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19)
2021 · Ricardo Garcia-Muñoz, Jesus Feliu, et al. · Irish Journal of Medical Science (1971 -) · 3
PDF
Battle of Thermopylae: 300 Spartans (natural Killer Cells Plus obinutuzumab) Versus the Immortal Warriors (chronic Lymphocytic Leukemia cells) of Xerxes’ Army
2019 · Ricardo García-Muñoz, María-Josefa Nájera, et al. · Future Science OA · 3
PDF
543 | Obinutuzumab‐induced Adcc as a Predictor of Minimal Residual Disease in Chronic Lymphocytic Leukemia: a Preliminary Study
2025 · R. García‐Muñoz, S. Rincon‐Lopez, et al. · Hematological Oncology · 2
PDF
Serology-based therapeutic strategy in SARS-CoV-2-infected patients
2021 · Ricardo Garcia-Muñoz, Giovanna Farfán-Quiroga, et al. · International Immunopharmacology · 2
PDF
SOX4 in chronic lymphocytic leukaemia: the forgotten transcription factor
2025 · Ricardo García-Muñoz, Jone Alberdi-Ballina, et al. · Blood Research · 1
PDF
510 | the Antibody‐dependent Cellular Cytotoxicity and Metabolic Tumor Volume Balance: a Novel Predictive Marker for Tumor Recurrence in Diffuse Large B‐cell Lymphoma
2025 · S. Rincon‐Lopez, P. Garrastachu‐Zumaran, et al. · Hematological Oncology
PDF
High NK Cell Levels at the End of Obinutuzumab Treatment Are Associated with Negative Minimal Residual Disease (MRD) in Chronic Lymphocytic Leukemia (CLL)
2025 · Ricardo García-Muñoz, Javier Larreina-Pérez, et al. · Research Square
PDF
A new case of Bicêtre hemoglobin in an adult male: clinical observations over a period of four years
2021 · Giovanna Farfán-Quiroga, Maria del Mar Hermosilla-Fernandez, et al. · Annals of Hematology
Works count: 8
Citation count: 11
H-index: 2
I10-index:
Year
Topic
Type